Form 8-K - Current report:
SEC Accession No. 0001641172-25-003526
Filing Date
2025-04-10
Accepted
2025-04-10 08:30:37
Documents
19
Period of Report
2025-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45412
2 ex1-1.htm EX-1.01 250164
3 ex5-1.htm EX-5.1 12170
4 ex5-1_001.jpg GRAPHIC 14257
5 ex99-1.htm EX-99.1 11005
6 ex99-2_001.jpg GRAPHIC 4409
7 ex99-2.htm EX-99.2 9591
  Complete submission text file 0001641172-25-003526.txt   603095

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE lucd-20250409.xsd EX-101.SCH 3012
9 XBRL LABEL FILE lucd-20250409_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE lucd-20250409_pre.xml EX-101.PRE 22357
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3811
Mailing Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017
Business Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 212 949 4319
Lucid Diagnostics Inc. (Filer) CIK: 0001799011 (see all company filings)

EIN.: 825488042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40901 | Film No.: 25826588
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)